Agendia Gets ISO Accreditation for Microarray-Based Breast Cancer Diagnostic | GenomeWeb

NEW YORK, Sept. 5 (GenomeWeb News) - Agendia, a Dutch firm that specializes in gene-expression services, said today that it has been granted ISO 17025 accreditation for its MammaPrint service, which assesses the risk of metastasis in breast cancer patients.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.